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w Cartilage Disorders: The importance of being sulphated 
(Lillian A Wallis (1 YYJ). Cm Bicll. 5, 225-227. 
The disease diastrophic dysplacta. a recessively inherited condi- 
tton whose tnantfestattons include alterations in the shape and 
form of the developing skeleton, ts characterized by short- 
limbed d\varfistn and problems such as curvature of the spine. It 
ts rare in world-wide terms, but common in Finland, where the 
carrier frequency can approach 1 in 30. In this mintreview, 
Wallis discusses the mapping of the gene responsible for the 
disorder by fine-structure linkage disequilibrium mapping. The 
gene has also been cloned and sequenced, and by sequence 
comparison is predicted to encode a novel sulphate transporter 
containing 12 transrnembratte helices, \vith highly charged 
cytoplasmic domains at both ends. Aberrant sulphate uptake was 
indeed seen in one pattent. lc seems likely that the decreased 
intracellular sulphatc levels affect the function of proteo- 
glycans, including aggrecan, which IS one of the major 
structural components of cartilage, attd heparan ,ulphate. 
which IS involved in many aspects of cell adhesion, growth 
~ttd morphogenesis. 
1 March 1 YY5. C~uwrrt Hiolc;y)J 
b Superantigens: Gazing into the crystal ball 
Pittg-Ning Hsu and Brigitte T Hither (IYYS). C~rrr. Biol. 
5.235-237. 
Superanttgens are microbial antigens that, once hound to mole- 
cults of the major histocotnpatibility complex (MHC), ittteract 
with an unusually large proportion ofT cells.T-cell recognttion 
of superantigen apparently requires only a single variable 
dotnaitt of the T-cell receptor, unlike recognition of normal 
antlgcn. The toxicity of bacterial supcranttgens, some of xvhich 
are involved in food poisonittg and toxic shock syndrome, may 
he mediated by their potent T-cell stirnulatory activity. In thts 
ttttnireview, Hsu and Huber discuss the recent determtnatiott of 
the crystal structures of two bacterial toxin superantigens cottt- 
plesed with MHC class II molecules and the resulting insights 
into the interactions between superantigens and MHC tttole- 
culrs. The new structural information reveals that the TSST-I 
superanttgen bind, across the peptide-binding groove of the 
MHC molecule. contacting the bound peptide, but the SEl3 
superantigen binds on one side of rhe MHC tnoleculc, acvay 
from the pepttde-bindink r groove. The finding that different 
toxins bind to very different parts of the MHC molecule ts 
unexpected; presuntably binding of the T-cell receptor to the 
tw;o complexes ts also very different. 
1 March IYYS, Cltrrorr Bio/oy!y) 
b Chrotnatin: Ga-ga over GAGA factor 
H Granok, BA Lrihovitch, CL3 Shaffer and SCI? Elgin (lYY5). 
C~rrr: Bid. 5.238~341. 
It IS well established that chromatin structure has an important 
role in the process of eukaryotic gene expresston. It has been 
difficult to study the factors that affect chrontatin structure irr 
vilio, since organisms that are mutant for genes encoding crittcal 
chromatin proteins are hard to identify and maintain. In this 
mtnireview. Granok ct al. discuss the recent dlscovrry that the 
chromatin factor GAGA, origtnally Identified as .t transcrip- 
ctonal activator, is encoded by the 7~it/,clr~l.~-likr (Zl) gene in 
Droso~~ltil~t. A large number of genes now appear to be targets of 
GAGA factor. ‘l i l tnutattons enhance ‘position effect v.nir+- 
tion’ irt l~it~c); in this phenometton, a specific pattern of gene 
inactivation is seen mhen inactive and acttve chrotnosomal 
domains are juxtaposed by chrontosomal rearrangement. Thts 
pattern is clonally inherited. Together Lvtth the finding that 
GAGA factor causes local disruption of nucleosotttc ~ssrmhly 
over a GAGA-factor binding site irl iJitr0. thi, observatton 
suggests that GAGA factor may help to establish and/or tnattt- 
tain nuclcosontc-free regiotts containing important gene reguld- 
tory srqurnces, maktn 3 them accessible to RNA polynterasc, 
for ex,tniple. 
1 March 1 YYJ. Clrr.rt,rlt Biolqgj 
b RNA-Protein Interactions: Diverse modes of recognition 
Dine Moras and Arnaud Poterszntatt (1 YYS). Crrrr: Bid. 
5,23%351. 
When you think of regulation of gene espressiott, you often 
think tirst of transcrtptional control. t3ut after the prttttary RNA 
transcript is produced. there several step, that can be modulated 
before the final protein product ts made. for example the spltclng 
and transport of KNA.These processes involve ttutnerous RNA- 
binding proteins. tttany of \vhtch carry an ‘RN1 tnocif’ nrhich ts 
responsible for RNA binding. A\ dthcussed ttt this tninireviecv, 
the recently determined crystal structut-e of the Ul A small 
nuclear rtbonucleoprotein (snRNP) tn cotttplcs \vith irs target 
sequence AUUGCAC has provtdrd a con~iderablc amount of 
information on the \vay that RNA is recognized by thts protetn. 
Together with \vhar is already known about RNA rrcognittott tn 
aminoacyl tRNA syttthetases. this structure may shed light on 
some cotnmon features of RNA-protein interaction\. 
1 March 1005. Cwwr~t Bi~>kl,~y 
F Structural characterization of viral fusion proteins 
Frederick M Hughson (lYY5). Clrrr: Bid. 5. XC-174. 
Eukaryotic cell\ need mentbratte fusion to allon- the tr,tn\port 
and tntport of protein\; gamete< need to fuse for fertilizatton to 
occur; and viru\cs need fustott to allo\v them to etttcl- crlls.The 
process of ntenthraltr fusion is poorly uttderjtood. Intluenza 
viru\ hetnagglutinin is the bes:t characterized protcttt \vtth 
tttemhrane fusion acttvit);. In this full-length review, Hugh11 
discusses recent \tt-uctural results that provide insight ittto the 
tttolecular event> of membrane fusion. The ttemaggluttnitt 
protein utider~ocs ettormous conformational changes upon 
exposure to the lo\v pH of the intracellular compartment tttto 
\vhich the metnbrdtte-bound virus is localized following ettdo- 
cytosis. These irreversible changes appear to propel the amino+ 
termtnal hydrophobic ‘fuston peptide’ into position to tttteract 
wtth the tarset tttembrattc. Further change\ modify the portion 
of the tnolecitle that is close to the viral membrane, perhaps 
making ir: more tlesiblc.This hypothetical tlextbiltty ha\ ttttpor- 
tant implications for the possible ttlechanisms by which 
hen~agglutmtn might facilitate fusion. 
1 March 1 YY5, Clrrrcrrr Biolqp)) 
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F A small peptide inhibitor of DNA replication defines the 
site of interaction between the cyclin-dependent kinase 
inhibitor p21WAF’ and proliferating cell nuclear antigen 
Emma Warbrick, David P Lane, David M Glover and Lynne S 
COX (1995). CUV~. Biol. 5,275-2X?. 
P21 wAF’ is a potent inhibitor of the cell-cycle regulatory cyclin 
dependent kinases (Cdks). It binds to proliferating cell nuclear 
antigen (PCNA), a processivity factor for DNA polymerase 6 
which is essential in DNA replication and repair, and is induced 
by the tumor suppressor protein ~53. p21WAF’ may thug be 
important in coordinating cell-cycle progression with DNA repli- 
cation and repair. Using the yeast two-hybrid screening method, 
the authors demonstrate a strong interaction between the central 
loop of PCNA and the carboxy-terminal region of p21 wAF1. A 20 
amino acid peptide derived from this region binds PCNA strongly 
and specifically and can inhibit SV40 DNA replication in vitro, 
demonstrating that inhibition of SV40 DNA replication by 
~21 wAF’ is a function of PCNA binding.These results suggest that 
drugs based on the p-1 3 WAF’-derlved peptide may be therapeuti- 
cally useful; they may be able to down-regulate the activity of 
PCNA in tumor cells, inhibiting their proliferation. 
1 March 1995. Cwrerzt Biolqqy 
F Evidence that SH2 domains promote processive phos- 
phorylation by protein-tyrosine kinases 
Bruce J Mayer, Hisamaru Hirai and Ryuichi Sakai (1995). Cum 
Bid. 5,296-305. 
The presence of SH2 domains, which bind to tyrosine-phospho- 
rylated peptides with high affinity, in non-receptor protein-tyro- 
sine kinases raises an interesting question: why would a kinase 
need a domain that cannot bind to the unphosphorylated sub- 
strate? One such kinase, Abl, requires its SH2 domain to malig- 
nantly transform cells. Exchanging the SH2 domain for an SH2 
domain from another protein also alters the spectrum of proteins 
phosphorylated by Abl in viva. Kinase substrates often contain 
several phosphorylation site? with similar sequences. One such 
substrate for Abl is p130CAS. Here, the authors show that the SH2 
domain is required for Abl to efficiently hyperphosphorylate 
p130 CAb in vitro. The most effective SH2 domain tested is that 
from the adaptor molecule, Crk, which is also the SW2 domain 
that is predicted to bind most strongly to phosphorylated sites in 
pl3C)‘:*“. They therefore propose that the SH2 domain binds 
tightly to substrates that are phosphorylated at one site, facilitatmg 
the processive phosphorylation at additional sites. Substrate speci- 
ficity can be broadened by an association between the kinase and 
proteins, such as Crk, that contain addltional SH2 domains; this 
may be important in malignant transformation by Crk. 
1 March 1995, Cwxwt Biolcy~ 
b Thioredoxin structure and mechanism: conformational 
changes on oxidation of the active-site sulfhydryls to 
a disulfide 
Arne Holmgren (1995). Stnrcture 3,23Y-243. 
Thioredoxin is present in all proteins from archaebacteria to man 
and has a large number of functions. In addition to its role in 
DNA synthesis as a hydrogen donor for the essential enzyme 
ribonucleotide reductase, thioredoxin provides general catalysis of 
thiol-disulfide exchange between a dithiol on one protein and a 
disulfide acceptor on another protein. The recent determination 
of high resolution solution structures of both the reduced and 
oxidized forms of human and Escheridzia coli thioredoxins, as 
reviewed by Holmgren, has provided new opportunities for 
understanding the catalytic activity of thioredoxin as well as the 
increasingly important role of thiol-redox regulation of protein 
activity in different biological systems (see also the paper by Qin 
ct al., brlow].The results support a catalytic model of protein 
disulfide reduction involving nucleophilic attack by the active-site 
Cys32 thiolate to form a transition-state mixed disulfide. 
Thioredoxins are also of wide interest due to the number of pro- 
teins with a thioredoxin fold (also reviewed in this issue by J.L. 
Martin, Structure 245-250). It appears from these structures that 
thioredoxin uses a chaperone-like mechanism of conformational 
changes to bind a diverse group of proteins, and uses fact thiol- 
disulfide exchange chemistry in a hydrophobic environment to 
promote high rates of disulfide reduction. 
15 March 1995, Structure 
b Hyperthermophiles: taking the heat and loving it 
Douglas C Rees and Michael WW Adams (1995). Stnrctwe 
3,251-254. 
This Ways & Means article focuses on the proteins from hyper- 
thermophiles, a recently discovered group of microorganisms 
capable of growing in high temperature environments that in 
some cases exceed 100 OC. The highly thermostable enzymes iso- 
lated from these organisms have a number of technical applica- 
tions including the polymerase chain reaction (made possible by 
hyperthermostable DNA polymerases), biocatalytis, and crystal- 
lization methods. Although the high resolution structures of only 
two hyperthermostable proteins have been determined so far, 
they provide some clues as to how such stability is achieved. 
Rather than relying on any one dominant type of interaction, 
these proteins appear to employ a number of subtle interactions 
involving surface energies, electrostatic interactions, increased 
stabilization of secondary structure, and packing effects. 
15 March 1995, Structure 
F Crystal structure of the MS2 coat protein dimer: impli- 
cations for RNA binding and virus assembly 
Chao-Zhou Ni, Rashid Syed, Ramadurgam Kodandapani, 
John Wickersham, David S Peabody and Kathryn R Ely 
(1995). Strucfure 3, 255-263. 
The coat protein from the MS2 bacteriophage self-aggregates to 
form an icosahedral shell which binds and encapsidates the 
single-stranded RNA genome. The protein also represses viral 
replicase synthesis by binding as a dimer to an RNA hairpin con- 
taining the translation-initiation region of the replicase gene. In 
addition to its genetic role, this binding event is an important first 
ctrp in nucleation of virus assembly.The authors report the high 
resolution crystal structure of the unassembled dimer; to obtain 
this structure, a mutant MS2 coat protein that cannot assemble 
into a viral capsid was used.This 1s the first time that high resolu- 
tion structures have been available for a viral protomer in both 
the isolated and asrembled states. Comparison with the structure 
of the intact virus shows differences in the orientation of two of 
the RNA-recognition residues, suggesting a conformational 
adjustment on binding RNA during the first step in the assembly 
process. At the end of the P-strand that contains these two 
residues, a Trp +Arg substitution influences capsid assembly, 
apparently by imposing conformational restriction on an adjacent 
loop, preventing critical intersubunit contacts in the capsid. 
15 March 1995, Structure 
F Structure of uncomplexed and linoleate-bound Candida 
cylindracea cholesterol esterase 
Debashis Ghosh, Zdzislaw Wawrzak,Vladimir Z Pletnev, Naiyin 
Li, Rudolf Kaiser, Walter Pangborn, Hans JGrnvall, Mary Erman 
and William L Duax (1995). Structure 3,279-288. 
Cholesterol esterase reversibly hydrolyzes cholesteryl linoleate 
and oleate, esters of fatty acids that are the major components of 
arterial plaque.The enzyme has a hydrophobic active-site cavity, 
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and a flap that could cover the active site but is open in the struc- 
ture as determined.The structure of the complex with cholesteryl 
linoleate reveals how the lipid and protein interact, and indicates 
that the carboxyl terminus of the protein may serve as a ‘gate’ for 
the release of product.The interactions of the substrate with the 
catalytic triad of the enzyme can also be seen. The protein crys- 
tallizes as a dimer, which may be a functionally active form of the 
enzyme. Comparison of the structure of cholesterol esterase to 
that of a triacylglycerol acyl hydrolase from Cardida npsn shows 
that 23 of the 55 residues that are different in the two proteins are 
located in the active site and dimer interface.These substitutions 
are responsible for the altered substrate specificity. 
15 March 1995, Structure 
b Solution structure of human thioredoxin in a mixed 
disulfide intermediate complex with its target peptide 
from the transcription factor NFKB 
Jun Qin, G Marius Clore, WM Poindexter Kennedy, Jeffrey R 
Huth and Angela M Gronenborn (1995). Structure 3,289-297. 
Human thioredoxin (h(TRX)) h as a key role in maintaining the 
redox environment of the cell. It has recently been shown that 
h(TRX) is responsible for activating the DNA-binding properties 
of the cellular transcription factor, NFKB, by reducing a disulfide 
bond involving the Cys62 residue of the ~50 subunit. A growmg 
number of transcription factors are thought to be regulated in 
thic \vay.To understand how h(TRX) recognizes the loop COII- 
taining Cys62, the authors have determined the solution structure 
of h(TKX) covalently linked to a 13-residue peptide correspond- 
mg to residues 56-68 of p50, a complex that represents a kineti- 
cally stable mixed di$ulfide intermediate along the reaction 
pathway. In addition to the disulfide bond between Cys32 of 
h(TRX) and Cys62 of ~50, the peptide is stabilized in a boot- 
shaped cleft of h(TRX) by hydrogen bonding and by electrostatic 
and van der Waals interactions.The structure allows predictions to 
be made about the specific requirements for h(TRX)-catalyzed 
disulfide bond reduction of proteins. 
15 March 1995, Sfructcrrc 
F Activity of the MAP kinase ERK2 is controlled by a 
flexible surface loop 
Jiandong Zhang, Faming Zhang, Llouglas Ebert, Melanie H 
Cobb and Elizabeth J Goldsmith (1995). Sfnrctlrn. 3,299%307. 
The mitogen-activated protein (MAP) kinase ERK2, a tightly 
regulated enzyme in the Ras-activated protein kinase cascade, is 
activated by phosphorylation at two sites, TyrlX5 and Thr183, 
that lie in the lip at the mouth of the catalytic site.To understand 
the roles of these sites in the activation of the kinase. the authors 
have determined the structures of four unphosphorylated ERK2 
mutants that have substitutions at one or both of these sites. 
Disorder is observed throughout the lip when Tyr185 i5 mutated. 
indicating that the stability of the lip is low. Therefore. only 
modest amounts of binding energy should be required to dis- 
lodge the hp for phosphorylation, and the lip may undergo a 
conformational change in the active structure. The structure of 
the inactive form is dependent on Tyrl85, but the structure of 
the active form requires bothTyr185 andThrl83, contributing to 
the tight control on the enzyme. The close proximity of the 
phosphorylation lip to the active site may also facilitate the tight 
regulation observed in MAP kinaser. 
15 March 1995, Stnrctrrw 
